An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia

Tamer A. Othman, Matthew E. Tenold, Benjamin N. Moskoff, Tali Azenkot, Brian A. Jonas

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences